Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Eukaryotic RNA Polymerases00:58

Eukaryotic RNA Polymerases

24.5K
RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
24.5K
The Nucleolus02:55

The Nucleolus

8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations.

Nature communications·2025
Same author

An RNA polymerase III tissue and tumor atlas uncovers context-specific activities linked to 3D epigenome regulatory mechanisms.

bioRxiv : the preprint server for biology·2025
Same author

Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations.

bioRxiv : the preprint server for biology·2024
Same author

Evidence of RNA polymerase III recruitment and transcription at protein-coding gene promoters.

bioRxiv : the preprint server for biology·2024
Same author

A Combinatorial Regulatory Platform Determines Expression of RNA Polymerase III Subunit RPC7α (<i>POLR3G</i>) in Cancer.

Cancers·2023
Same journal

Molecular Interplay of PARN and Telomerase: Tail Modifiers and Disease Implications.

Wiley interdisciplinary reviews. RNA·2026
Same journal

Exploring New Frontiers in Bone Metabolism: Role and Potential of lncRNA DANCR.

Wiley interdisciplinary reviews. RNA·2026
Same journal

Functional Inclusion of RNA Biology in the Tethered Extracellular Matrix.

Wiley interdisciplinary reviews. RNA·2026
Same journal

Structural and Functional Diversity of RNA-Containing Toxin-Antitoxin Systems.

Wiley interdisciplinary reviews. RNA·2026
Same journal

Promoter-Targeting RNA Technologies: An Epigenetic Strategy for Gene Activation and Gene Silencing.

Wiley interdisciplinary reviews. RNA·2026
Same journal

LncRNA PCAT18: Roles and Mechanisms in Human Cancers.

Wiley interdisciplinary reviews. RNA·2026
See all related articles

Related Experiment Video

Updated: Aug 11, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

832

The Pol III transcriptome: Basic features, recurrent patterns, and emerging roles in cancer.

Sihang Zhou1, Kevin Van Bortle1,2

  • 1Department of Cell and Developmental Biology, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.

Wiley Interdisciplinary Reviews. RNA
|February 8, 2023
PubMed
Summary
This summary is machine-generated.

The RNA polymerase III (Pol III) transcriptome, comprising short noncoding RNAs (ncRNAs), plays diverse roles in gene regulation and cellular activities. Its dysregulation in cancer highlights ncRNAs

Keywords:
RNA polymerase IIIcancer biologynoncoding RNAsmall RNAtranscription

More Related Videos

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

185
Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

12.4K

Related Experiment Videos

Last Updated: Aug 11, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

832
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
09:01

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

185
Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

12.4K

Area of Science:

  • Molecular Biology
  • RNA Biology
  • Cancer Research

Background:

  • The RNA polymerase III (Pol III) transcriptome consists of short, structured noncoding RNAs (ncRNAs) essential for fundamental cellular processes.
  • These ncRNAs mediate functions including gene regulation, RNA processing, protein targeting, and translation, involving crucial RNA-protein interactions.
  • Higher eukaryotes exhibit an expanded Pol III transcriptome with newly evolved ncRNAs regulating autophagy, immunity, and translation.

Purpose of the Study:

  • To review the fundamental features and functions of the Pol III transcriptome.
  • To examine the dysregulation and dysfunction of individual ncRNAs within the Pol III transcriptome in the context of cancer.
  • To identify common patterns and mechanisms underlying the role of the Pol III transcriptome in cancer progression.

Main Methods:

  • Literature review of existing research on RNA polymerase III transcription.
  • Analysis of functional roles of various ncRNAs transcribed by Pol III.
  • Examination of evidence linking Pol III ncRNAs to cancer development and patient outcomes.

Main Results:

  • Pol III transcription is frequently upregulated in cancer, with specific ncRNAs associated with disease progression and survival.
  • Newly evolved ncRNAs contribute to broader cellular functions, including autophagy and immune signaling.
  • Emerging patterns in cancer include shared functional motifs like molecular scaffolding, protein sequestration, and immunostimulatory activities.

Conclusions:

  • The Pol III transcriptome plays a multifaceted role in cancer, extending beyond basic cellular functions.
  • Dysregulation of Pol III ncRNAs contributes significantly to cancer progression and impacts patient survival.
  • Understanding these ncRNAs offers potential therapeutic targets and insights into cancer biology.